Encellin

company

About

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

  • San Francisco,California,United States
  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$5.90M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes.

It was founded in 2016 and is headquartered in San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$5.90M
Encellin has raised a total of $5.90M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2021 Seed $5.90M 4 Khosla Ventures
SV Latam Capital
Detail
Aug 22, 2019 Seed 4 Detail
May 1, 2017 Grant 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
6
Encellin is funded by 6 investors. Khosla Ventures and SV Latam Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Khosla Ventures Yes Seed
SV Latam Capital Yes Seed
Sand Hill Angels Seed
Y Combinator Seed
Formic Ventures Seed
MedTech Innovator Grant

Employee Profiles

Number of Employee Profiles
14
Encellin has 14 current employee profiles, including Employee Ronald Martell
Employee
Advisor
Executive
Employee
Executive